Biofrontera Inc. (BFRI)
USD 0.81
(0.32%)
USD 0.81
(0.32%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 39.95 Million USD | 2.91% |
| 2022 | 35.87 Million USD | -3.6% |
| 2021 | 37.2 Million USD | 105.38% |
| 2020 | 18.11 Million USD | -36.86% |
| 2019 | 28.69 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 8.45 Million USD | -9.17% |
| 2024 Q1 | 9.43 Million USD | 7.22% |
| 2023 Q3 | 9.02 Million USD | -21.88% |
| 2023 FY | 36.91 Million USD | 2.91% |
| 2023 Q4 | 8.79 Million USD | -2.47% |
| 2023 Q2 | 11.54 Million USD | 17.51% |
| 2023 Q1 | 9.82 Million USD | -3.73% |
| 2022 Q2 | 10.01 Million USD | 29.88% |
| 2022 Q1 | 7.71 Million USD | -16.88% |
| 2022 FY | 35.87 Million USD | -3.6% |
| 2022 Q4 | 10.2 Million USD | 28.63% |
| 2022 Q3 | 7.93 Million USD | -20.76% |
| 2021 FY | 37.2 Million USD | 105.38% |
| 2021 Q4 | 9.27 Million USD | -46.22% |
| 2021 Q3 | 17.25 Million USD | 200.1% |
| 2021 Q2 | 5.74 Million USD | 16.78% |
| 2021 Q1 | 4.92 Million USD | 18.23% |
| 2020 Q2 | 4.15 Million USD | -26.77% |
| 2020 FY | 18.11 Million USD | -36.86% |
| 2020 Q4 | 4.16 Million USD | -3.23% |
| 2020 Q3 | 4.3 Million USD | 3.44% |
| 2020 Q1 | 5.67 Million USD | 0.0% |
| 2019 FY | 28.69 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bright Green Corporation | 8.25 Million USD | -384.183% |
| Alpha Teknova, Inc. | 45.85 Million USD | 12.866% |
| ANI Pharmaceuticals, Inc. | 195.98 Million USD | 79.611% |
| Aquestive Therapeutics, Inc. | 44.85 Million USD | 10.913% |
| Collegium Pharmaceutical, Inc. | 159.2 Million USD | 74.901% |
| Cosmos Health Inc. | 26.18 Million USD | -52.627% |
| Journey Medical Corporation | 54.59 Million USD | 26.807% |
| Embecta Corp. | 528.4 Million USD | 92.438% |
| Esperion Therapeutics, Inc. | 271.89 Million USD | 85.304% |
| Dynavax Technologies Corporation | 219.14 Million USD | 81.766% |
| Intra-Cellular Therapies, Inc. | 590 Million USD | 93.227% |
| Pacira BioSciences, Inc. | 326.37 Million USD | 87.757% |
| PainReform Ltd. | 9.58 Million USD | -316.934% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -204.462% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -204.462% |
| SCYNEXIS, Inc. | 51.84 Million USD | 22.93% |
| Safety Shot Inc | 12.1 Million USD | -229.975% |
| China SXT Pharmaceuticals, Inc. | 3.06 Million USD | -1201.94% |
| Procaps Group, S.A. | 199.47 Million USD | 79.968% |
| Theratechnologies Inc. | 72.75 Million USD | 45.078% |
| Harrow Health, Inc. | 89.97 Million USD | 55.588% |
| Sonoma Pharmaceuticals, Inc. | 9.44 Million USD | -323.026% |
| DURECT Corporation | 43.71 Million USD | 8.592% |
| Supernus Pharmaceuticals, Inc. | 529.01 Million USD | 92.446% |
| Cronos Group Inc. | 96.7 Million USD | 58.681% |
| OptiNose, Inc. | 85.1 Million USD | 53.046% |
| Ironwood Pharmaceuticals, Inc. | 232.12 Million USD | 82.785% |
| Kala Pharmaceuticals, Inc. | 39.15 Million USD | -2.059% |
| RedHill Biopharma Ltd. | -9.56 Million USD | 517.937% |
| Organogenesis Holdings Inc. | 314.13 Million USD | 87.28% |
| Guardion Health Sciences, Inc. | 9.73 Million USD | -310.643% |
| Cumberland Pharmaceuticals Inc. | 43.04 Million USD | 7.16% |
| Radius Health, Inc. | 265.92 Million USD | 84.974% |
| Universe Pharmaceuticals INC | 13.84 Million USD | -188.681% |
| ProPhase Labs, Inc. | 37.85 Million USD | -5.566% |
| Phibro Animal Health Corporation | 260.29 Million USD | 84.649% |
| Procaps Group S.A. | 187.24 Million USD | 78.66% |
| Alvotech | 285.43 Million USD | 86.001% |
| TherapeuticsMD, Inc. | 9.82 Million USD | -306.707% |
| Viatris Inc. | 5.96 Billion USD | 99.33% |
| Rockwell Medical, Inc. | 15.37 Million USD | -159.913% |
| Aytu BioPharma, Inc. | 59.84 Million USD | 33.224% |
| SIGA Technologies, Inc. | 22.04 Million USD | -81.277% |
| Tilray Brands, Inc. | 251.35 Million USD | 84.103% |
| Lifecore Biomedical, Inc. | 49.03 Million USD | 18.514% |
| Shineco, Inc. | 17.94 Million USD | -122.637% |
| PetIQ, Inc. | 192.72 Million USD | 79.266% |
| Regencell Bioscience Holdings Limited | 3.99 Million USD | -901.193% |
| Incannex Healthcare Limited | 30.05 Million USD | -32.962% |
| Neurocrine Biosciences, Inc. | 1.59 Billion USD | 97.497% |
| Alimera Sciences, Inc. | 62.64 Million USD | 36.21% |
| Silver Spike Investment Corp. | 762.49 Thousand USD | -5140.58% |
| Assertio Holdings, Inc. | 368.58 Million USD | 89.159% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.88 Million USD | -578.932% |
| Petros Pharmaceuticals, Inc. | 17.8 Million USD | -124.381% |
| Clever Leaves Holdings Inc. | 21.16 Million USD | -88.762% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -89.9% |
| Avadel Pharmaceuticals plc | 164.96 Million USD | 75.777% |
| Hempacco Co., Inc. | 7.59 Million USD | -426.022% |
| Talphera, Inc. | 11.99 Million USD | -233.158% |
| Alvotech | 285.43 Million USD | 86.001% |
| Eagle Pharmaceuticals, Inc. | 140.71 Million USD | 71.603% |
| Lantheus Holdings, Inc. | 344.9 Million USD | 88.414% |
| Currenc Group, Inc. | 24 Million USD | -66.481% |
| Kamada Ltd. | 45.42 Million USD | 12.035% |
| Indivior PLC | 911 Million USD | 95.614% |
| Evoke Pharma, Inc. | 12.4 Million USD | -222.0% |
| Flora Growth Corp. | 10.57 Million USD | -277.72% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -89.9% |
| Evolus, Inc. | 189.75 Million USD | 78.942% |
| HUTCHMED (China) Limited | 436.23 Million USD | 90.84% |
| Amphastar Pharmaceuticals, Inc. | 154.13 Million USD | 74.075% |
| Akanda Corp. | 3.48 Million USD | -1047.091% |